These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1802564)

  • 1. Elimination of vancomycin in patients on continuous arteriovenous hemodialysis.
    Reetze-Bonorden P; Böhler J; Kohler C; Schollmeyer P; Keller E
    Contrib Nephrol; 1991; 93():135-9. PubMed ID: 1802564
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous arteriovenous hemodiafiltration: predicting the clearance of drugs.
    Vos MC; Vincent HH
    Contrib Nephrol; 1991; 93():143-5. PubMed ID: 1802566
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.
    Jeffrey RF; Khan AA; Prabhu P; Todd N; Goutcher E; Will EJ; Davison AM
    Artif Organs; 1994 Jun; 18(6):425-8. PubMed ID: 8060251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased vancomycin elimination with continuous hemofiltration.
    Lau AH; Kronfol NO; John E
    ASAIO Trans; 1987; 33(3):772-4. PubMed ID: 3676016
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
    Przechera M; Bengel D; Risler T
    Contrib Nephrol; 1991; 93():131-4. PubMed ID: 1802563
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP; Kox WJ; Brown EA
    Contrib Nephrol; 1991; 93():117-9. PubMed ID: 1802558
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous arteriovenous hemofiltration improvement by adding diffusion and adsorption.
    Marangoni R; Civardi F; Savino R; Masi F
    Contrib Nephrol; 1991; 93():156-61. PubMed ID: 1802570
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of vancomycin during hemofiltration.
    Rawer P; Seim KE
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):529-31. PubMed ID: 2504595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlactemia in patients undergoing continuous arteriovenous hemofiltration with dialysis.
    Reynolds HN; Belzberg H; Connelly J
    Crit Care Med; 1990 May; 18(5):582. PubMed ID: 2328607
    [No Abstract]   [Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
    Lawless S; Restaino I; Azin S; Corddry D
    Clin Pharmacokinet; 1993 Jul; 25(1):80-2. PubMed ID: 8354019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of vancomycin during continuous arteriovenous hemodiafiltration.
    Bellomo R; Ernest D; Parkin G; Boyce N
    Crit Care Med; 1990 Feb; 18(2):181-3. PubMed ID: 2298011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin clearance in high-volume venovenous hemofiltration.
    Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
    Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies.
    Hernandez SH; Howland M; Schiano TD; Hoffman RS
    Clin Toxicol (Phila); 2015; 53(10):941-9. PubMed ID: 26484583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis.
    Davies SP; Reaveley DA; Brown EA; Kox WJ
    Crit Care Med; 1991 Dec; 19(12):1510-5. PubMed ID: 1959370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
    Vos MC; Vincent HH; Yzerman EP
    Intensive Care Med; 1992; 18(5):282-5. PubMed ID: 1527259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q; Zhu ZH; Ge M; Ge WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance.
    Macias WL; Mueller BA; Scarim SK
    Clin Pharmacol Ther; 1991 Dec; 50(6):688-94. PubMed ID: 1752113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.